© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ciclopirox entered the world of medicine in the 1970s, at a point when fungal infections routinely outmaneuvered many available treatments. Early research tracked the molecule’s origins to chemists searching for something gentler than old-school antifungals but tough enough to clear persistent dermatophytes. Over decades, clinicians saw real-world benefits—athletes’ foot and nail fungus rarely stood a chance—so the compound made itself at home on pharmacy shelves. Patents rolled in as the drug grew in scientific reputation, and generics soon followed. Hospitals and clinics adapted its formulations, turning to it in cases where ointments and salves from the past fell short. In these years, researchers logged thousands of pages on its performance, observed its resistance profile, and laid groundwork for further synthetic modifications.
Ciclopirox finds its home in creams, lacquers, gels, and shampoos, thanks mainly to its broad action against yeast and filamentous fungi. Most people know the drug through topical nail solutions or treatments for skin mycoses. A prescription often covers cases of tinea, seborrheic dermatitis, or candidiasis that don’t budge with over-the-counter stuff. Some physicians also rely on ciclopirox in immunocompromised folks, where keeping an infection from spreading counts for everything. It doesn’t have the same systemic toxicity as oral antifungals, so skin doctors and podiatrists feel comfortable reaching for it. Pharmacies in many countries stock generic ciclopirox, and the ingredient shows up in combination products with corticosteroids or other antifungals.
Ciclopirox itself comes as a white crystalline powder, with a slight musty odor that’s hard to miss once you’ve handled the raw compound. Chemically, ciclopirox uses a pyridone ring backbone—an arrangement that pushes its ability to penetrate fungal membranes and disrupt essential processes. Its solubility leans toward alcohol and propylene glycol, so most commercial formulas depend on blending agents to spread the active to nails or scalp. At a molecular weight of 207.22 g/mol and a melting point just above 140°C, ciclopirox keeps its structure stable through manufacturing and storage. This robustness lets pharmacies prepare consistent preparations without decomposition. The chemical sits at a neutral pH in standard solutions, but manufacturers sometimes tweak the environment with buffers or chelators to accommodate stability or shelf life.
Pharmaceutical labeling for ciclopirox products spells out concentration ranges that matter for real-world outcomes. Creams and solutions tend to sit near the 1% mark, while nail lacquers, often at 8%, deliver slow-release protection over months of use. The packaging runs through storage guidelines—cool, dry, and out of the reach of children—and includes warnings against use near eyes or on mucous membranes. Companies list inactive ingredients not just for transparency, but to address concerns from those with allergies or sensitivities. Expiry dates reflect rigorous stability testing with factors like temperature cycling and humidity challenge, overseen by agencies like the FDA or EMA. Each batch carries a lot number traceable in case of recalls or adverse event tracking, a fact that bolsters confidence from prescribers and patients alike.
Large-scale synthesis of ciclopirox starts with pyridone derivatives, which get funneled through alkylation reactions and then refined with selective cyclization. This careful chemistry lets manufacturers keep the product free of unwanted isomers or byproducts, which might otherwise compromise the final product’s clinical use. After batch production, purification steps strip out impurities, yielding a raw compound that meets pharmacopoeial standards. Once isolated, the drug gets suspended or dissolved into a base, followed by homogenization and sterile packaging to minimize contamination. Small compounding pharmacies often order pharmaceutical-grade powder to prepare custom doses for specific patients, such as those with allergies to commercial excipients. The equipment used, from jacketed mixing tanks to high-shear homogenizers, helps ensure consistency across every bottle or tube.
Medicinal chemists have explored plenty of ways to tweak ciclopirox, aiming to boost its antifungal punch or smooth out pharmacokinetic quirks. Derivatization along the cyclohexyl and pyridone rings can adjust lipid solubility, a trick that sometimes yields deeper tissue action. Some labs add halogens to test for broader spectrum or improved resistance to enzymatic breakdown by fungi. Most studies, so far, have found the parent compound covers the broadest range of bugs, but newer analogues draw interest for topical delivery beyond fungal targets. Reaction with specific chelators—like EDTA—sometimes serves to heighten the drug’s penetration or change the release profile in lacquer systems. These modifications open up new intellectual property, driving ongoing competition among brand and generic manufacturers.
Ciclopirox hides under several names in different corners of the world. People may encounter it as ciclopirox olamine, an alternative salt form that aids with water solubility and formulation. In dermatology clinics across Europe, it goes by Batrafen, Penlac, or Loprox. Chemists recognize it in research as 6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone, while regulatory filings document both the base and olamine salt. Since generics have flourished, one can often spot local names on shelves or in online databases, but the backbone structure between brands remains the same.
Handling ciclopirox in the lab or manufacturing setting calls for gloves, masks, and eye protection, especially during bulk powder transfers. In the event of a spill, solid materials get swept up and handled as pharmaceutical waste, while residues need thorough wipe-down with alcohol-based cleaners. Regulatory agencies require safety data sheets to accompany shipments, listing acute toxicity, fire hazard scores, and first-aid measures for accidental exposure. In clinical contexts, most topical uses show only rare hypersensitivity reactions—redness, burning, or itch—so adverse event tracking remains a top priority for hospital pharmacists. Regulatory agencies monitor batches closely, and any spike in complaints gets traced with batch numbers to the source production line. These standards keep product recalls quick and targeted, protecting public health.
Ciclopirox finds wide use in dermatology and podiatry clinics, tucked into formularies for almost every hospital ward that handles immunocompromised patients, children, or seniors. Salons and nail spas sometimes point customers toward physician-prescribed lacquers for stubborn nail infections. Outside skin and nail care, regulatory agencies cleared ciclopirox shampoo for scalp conditions like seborrheic dermatitis and dandruff, especially for those failing over-the-counter antifungal shampoos. Researchers continue to test it against less traditional targets—think rare molds or resistant yeast strains—often in transplant clinics or intensive care units, where treatment options run thin.
In research settings, ciclopirox gets a lot of attention as a model molecule for new antifungal screening. Labs run resistance assays to map emerging trends and compare the drug’s performance to newer azoles and allylamines. Several studies in recent years explore its action against biofilm-forming yeasts, with promising results that suggest the drug could work for device-related infections—like catheters or prosthetic joints—where most agents fall flat. Clinicians have tested ciclopirox in combination therapy, hoping for synergy with other antifungals or anti-inflammatory drugs to shorten treatment windows. The focus on alternative formulations—sprays, patches, and nail insertions—drives innovation in drug delivery circles. Scholars also keep an eye on genetic markers for resistance, using this molecule as a probe for how fungi adapt in a world awash with antifungals.
Toxicity research on ciclopirox points to a wide therapeutic window when used topically, which lines up with decades of clinical experience. Animal studies established low systemic absorption through healthy skin, with only trace levels detected in blood or urine after repeated applications. Human patch trials show irritation in a sliver of subjects, usually those with existing eczema or ultra-sensitive skin, but the lack of mutagenic or carcinogenic signals in long-term studies offers reassurance for public health. People with open wounds or broken skin sometimes absorb more, so physicians tend to watch closely in these cases, especially in young children or the elderly. Neither teratogenic outcomes nor reproductive issues pop up in the literature, and toxicologists monitor ongoing real-world data through global surveillance registries to catch rare adverse outcomes.
Looking ahead, ciclopirox seems set for further exploration in resistant fungal infections where modern drugs face pushback. With the steady rise of antimicrobial resistance, repurposing older molecules like ciclopirox often pays dividends, especially in settings where cost and safety matter. Researchers have hinted at potential new uses—such as antiviral effects or synergy with antibiotics—though these studies remain in early days. Advances in formulation science could see smarter delivery forms, like nano-carriers or targeted release systems, to make longstanding treatments even more effective. Ongoing clinical trials, coupled with robust pharmacovigilance, promise to keep the molecule’s track record solid as health systems adapt to changing fungal landscapes. With a dedicated base in generic manufacturing and research funding, ciclopirox stands ready for another generation of innovation.
Fungal infections sneak up on people. Maybe a toenail starts looking odd, or a patch of skin turns red and scaly. These things feel small, but anyone who’s tried to deal with stubborn athlete’s foot or nail fungus knows how stubborn they get. Ciclopirox enters the scene as a remedy for many of these situations. Hospitals, primary care clinics, and pharmacies stock this antifungal to target local infections that throw the day off-balance.
I remember the first time a patient asked me about a strange rash that no home remedy would clear. Over-the-counter creams failed, and embarrassment kicked in. That patient needed a treatment with scientific backing. Ciclopirox comes recommended by dermatologists for tinea—what most call ringworm—and seborrheic dermatitis, the cause behind those flaky, red patches beside the nose or on the scalp. For fingernails turning yellow and thick—onychomycosis—prescription nail lacquer forms of ciclopirox go to work.
Fungal infections cause discomfort beyond the skin. Some folks worry about showing their hands in public, skip outings, or feel irritated by the itch. The U.S. Food & Drug Administration (FDA) reviewed ciclopirox nail lacquer and gave official approval to its use in treating nail fungus. With years of clinical studies backing up its use, doctors turn to it regularly for both minor and nagging cases.
Unlike older antifungals that just slow fungus down, ciclopirox punches holes in the invader’s defenses. It blocks the fungus from growing and even gets rid of the infection. Topical creams work on shallow skin infections. Nail solutions sink through the tough nail surface to kill what’s beneath. Studies published in the Journal of the American Academy of Dermatology found that repeated use of ciclopirox, combined with trimming and taking care of nails, helps clear infection and prevent relapses.
The relief it brings isn’t just about comfort. Fungal infections, if ignored, can spread, become chronic, or lead to secondary bacterial infections. These complications hit vulnerable groups hardest: the elderly with diabetes, people who sweat a lot, and young children at daycare. Fast, targeted treatment offers more than itch relief; it lowers future health costs and reduces sick days.
Not everyone finds ciclopirox at their neighborhood pharmacy. Insurance coverage isn’t always clear, and some get stuck with high co-pays or have trouble following up on prescriptions. A lot of people skip doses when they don’t see fast results—nail infections especially move at a glacial pace. I always tell patients to stick with the treatment as instructed, trim infected nails often, and let fresh air in. Trust takes time, but visible improvement arrives for those who keep up.
Pharmacists, doctors, and nurses can step up by guiding people through the right way to use ciclopirox. Handouts, phone check-ins, or posted reminders at clinics keep usage on track. For tougher cases, health professionals watch for signs that another problem is hiding behind the infection—maybe diabetes, poor circulation, or immune issues—and address these head-on.
People deserve relief from fungal misery, and ciclopirox continues to earn its spot on pharmacy shelves. Researchers keep looking for new formulations—sprays, combined therapies, even easier applications—to make treatment simple and reliable. Hearing what matters to people in clinics and at home shapes better care. As fungal infections keep showing up, the value of ciclopirox—and patient perseverance—remains clear.
Fungal infections tend to show up right where you don’t want them. Between the toes, under the nails, in rashes that itch and look a bit alarming. Ciclopirox cream and solution have become staples in fighting off these common skin issues. A lot of people just want a straightforward way to feel better and stop the itch or embarrassment. If you’ve ever tried to treat something like athlete’s foot or nail fungus, you know the hurdles: persistence, mess, frustration.
Cream feels simple. Wash your hands and the area you want to treat. Get it dry—fungus loves moisture. Use a thin layer. Rub it in and forget about piling it on thickly. I’ve seen people cover the skin like they're frosting a cake, but too much just makes a greasy mess. Keep the area open to air as much as possible. Afterward, clean your hands again. This routine keeps you from spreading fungus to new spots.
Don’t cover up the area tightly unless your doctor says so. Socks and shoes can make things sweat more, which defeats the point. Loose clothing and time to air out work better. Sticking to a gentle routine beats switching back and forth between creams or skipping days. Fungal infections can hang on if you don’t stay consistent, so marking it on a calendar or tying it to another daily habit helps.
Nail fungus laughs at shortcuts. Solutions like ciclopirox reach where thicker creams can’t, but they need commitment. Clean the nail. Use nail clippers for dead or loose bits. Wipe away any dirt or polish, since those just block the medicine from soaking in. Brush the solution on the nail and under the edge if you can. Don’t worry about getting every millimeter—just make contact with the nail and skin at the base.
Let it dry before moving on with your day, especially if you’re putting on socks or gloves. Don’t try to seal it with bandages or add anything on top. Once a week, remove the old layers with alcohol or as your doctor directs. It takes a long time to grow out a healthy nail, so patience and discipline make all the difference. I’ve seen people stop midway, convinced it's not working fast enough. That only helps the fungus bounce back. Playing the long game wins here.
Skin infections spread quickly in homes and shared spaces, and they tend to knock your confidence down a notch. Applying medicine the right way makes real changes in how fast you heal—and how likely you dodge repeat infections. According to dermatologists and public health experts, improper use of antifungal creams explains a lot of relapses and stubborn rashes.
Simple things like using your own towel, keeping shower floors clean, and treating footwear with antifungal powder stop the cycle. Check in with a health care provider if things don’t improve or get worse. Sometimes a different medicine or a stronger prescription can help, and ruling out other skin conditions saves time and discomfort.
Sticking to instructions isn’t just about following orders—it’s about getting your life back to normal. With fungal skin woes, doing the little things right each day does more than any miracle cream or one-size-fits-all cure.
Ciclopirox has served people dealing with nail fungus, athlete’s foot, and a few stubborn skin conditions. It comes as a topical cream, nail lacquer, and sometimes a shampoo. Many folks trust it to clear up red, itchy rashes, especially after other options fail. But too often, people miss the warning about its possible side effects. Small problems sometimes get brushed aside until they turn into bigger issues.
After applying ciclopirox, skin might tingle, itch, or even sting for a few minutes. Some redness shows up in patches. These effects catch people off guard, but they do not usually last for more than a day or two. Doctors see these reactions fairly often, especially the first time someone tries the medication. A study in the Journal of Drugs in Dermatology reported mild skin burning or itching in nearly 1 out of 10 users.
What worries me most: skipping patch tests. Smearing the medicine over a large area without seeing whether the skin can handle it increases risk. Testing a small spot—on the arm or foot—helps gauge reaction without much risk.
A few unfortunate folks run into swelling, blistering, and sores after applying ciclopirox. Sometimes, pain crops up, and the skin might even peel. A burning pain deeper than itchiness could signal an allergy. If you spot hives, swelling, or trouble breathing, the smart move is to call a doctor or get emergency help. Serious allergies remain rare, but anyone with a history of contact dermatitis or strong reactions to skin products needs to mention it before starting this medicine.
Ciclopirox nail lacquer usually gets used for fungal nail infections. Sometimes the skin around the nail thickens or crusts, especially if the nail bed is already inflamed. It’s easy to blame dry weather or poor shoes, but if the skin keeps peeling or turns very red, that’s a signal to stop. People might also notice nails turning brown or white, which makes many think the infection is getting worse. In truth, the medicine can cause discoloration, especially if used with harsh removers.
Moisturizing after applying ciclopirox helps. In my practice, patients report fewer side effects if they let the area dry before putting on socks or shoes. Using the medicine at bedtime gives it time to work without rubbing off. Skipping harsh soaps and using lukewarm water instead of hot water preserves the skin’s barrier, cutting down on burning and irritation.
Side effects get ignored too easily, especially with over-the-counter versions. Pharmacists play a big role. They can walk people through side effect warnings and share tips for protecting skin. The FDA lists only a handful of serious risks for ciclopirox, but it’s not wise to take that as a free pass. Track any new spots or rash, and make note of changes in skin over a week or two. This simple tracking can help someone catch trouble early and avoid bigger problems down the road.
Over the counter or with a prescription, Ciclopirox helps treat nail fungus, athlete’s foot, ringworm, and a handful of other stubborn skin infections. Popular as nail lacquer or cream, Ciclopirox gets straight to the point: beating back the growth of fungus and clearing infections that hijack toenails or fingernails. Few things test your patience more than staring at the same ugly nail month after month, wondering if your efforts amount to anything.
No magic bullet turns a yellow, crumbly nail clear and shiny in a week. Dermatologists who treat foot and nail problems see this every day. Most people notice some change within two or three weeks, like less itching or flakiness if the infection is on the skin. In my own use of antifungal creams for athlete’s foot after long gym sessions, the deep itch fades in about ten days, but complete clearing pushes out to three or even four weeks.
On nails, though, results crawl. A healthy nail doesn’t grow overnight. Fingernails need about four to six months to reach full health after an infection, but toenails push closer to nine to twelve months. Ciclopirox starts fighting fungus as soon as you put it on, chipping away at the infection’s root, but it won’t undo damage that’s already happened. You’re waiting for fresh nail to grow in. That calendar crawl leaves many people frustrated and ready to quit early.
Success with Ciclopirox depends on sticking to the routine for the long haul. Skipping applications lets the fungus regroup. Not removing the old lacquer each week can keep the medicine from soaking into the nail. Diabetes, immune problems, or poor foot hygiene slow healing, too. Research from the Journal of the American Academy of Dermatology gives Ciclopirox a success rate of about 29% to 35% clear nails after a year of use. That’s not perfect, but it’s a lifeline in cases where pills can’t be used due to side effects or drug interactions.
Wash the nails daily with soap and water, then dry them before each treatment. Avoid nail polish or artificial nails during the process. Cut back thickened nails for better penetration. Set a timer if forgetfulness haunts your health routine — missed days mean missed progress. Fungal spores love dark, damp shoes, so airing out footwear and wearing clean socks makes a difference over time.
Fungal nail and skin infections frustrate so many people because they’re slow to clear and easy to catch again. Around 10% of the population deals with nail fungus at some point. Treatment takes patience, not just a bottle of lacquer. Health professionals talk about setting realistic expectations and using proven strategies for prevention. Locking in the habit and tending to overall health gives Ciclopirox its best shot. No quick fix exists, but steady effort can hand people back healthy nails and feet.
Fungal nail infections don’t just look bad. They bring a good bit of embarrassment and, plenty of times, some discomfort too. As someone who’s gone through the routine of cloudy, crumbling nails and the trip to the pharmacy for help, I know prescription options don’t always promise quick fixes. Over-the-counter creams rarely do the trick for toenails. Prescription lacquers have become more common, and ciclopirox stands out among them.
Back in the 1980s and 1990s, researchers saw ciclopirox as something that could knock out more than just athlete’s foot. Ciclopirox nail lacquer (often sold as Penlac) showed up in pharmacies as an answer for onychomycosis, the fancy name for fungal nail infections. Doctors started prescribing it, hoping for safer results than what oral antifungals could offer.
Oral medications like terbinafine clear nails better but bring the risk of liver side effects and interactions with other prescriptions. Not everyone can take pills for three months straight, especially with other health problems. Applying ciclopirox directly on the nail feels safer and easier on the body. Users don’t need to worry about stomach issues or blood work. It’s less intrusive.
FDA gave the green light to ciclopirox lacquer for mild to moderate fungal infections on fingers and toes. So, for a single affected nail or a couple of thickened toenails, it has turned into a first choice. But doctors and patients should keep their expectations in check. The lacquer takes time—almost a year of daily painting, scraping, and trimming. The success rate stays lower than with oral therapy.
Studies tell us ciclopirox lacquer clears infection in 5-12% of cases. That’s not much to get excited about, but for someone unable to handle oral meds, it helps. Some people use it with debridement—regular removal of dead or thickened nail by a foot doctor—to give the medicine a better shot at reaching the fungus.
In my work, I’ve met people who saw improvement in the nail’s look but not a complete cure. For those frustrated by years of hiding thick yellow toenails, some improvement can matter. Clean nail edges and less crumbling let patients wear sandals with more confidence.
Combining approaches seems to work best. Some dermatologists suggest pairing ciclopirox lacquer with oral antifungals during tough infections. Others recommend using urea cream to thin down the nail plate so ciclopirox can soak in deeper. Consistent use and patience play a role. Missing days slows progress, and a rushed routine leads to disappointment.
Research into better topical antifungals continues. Tavaborole and efinaconazole have nudged ahead of ciclopirox in effect, but cost stands in the way for many. Insurance doesn’t always cover the fancy new bottles. So ciclopirox, generic and trusted, stays on the shelf.
Anyone dealing with stubborn nail fungus should speak with a healthcare professional. Diagnosing what’s really wrong, managing expectations, and updating treatment if things don’t improve helps avoid months of wasted effort.
For mild infections, ciclopirox offers a safer, affordable choice, especially for people who want to avoid pills. But results take time, and thick, messy infections rarely clear with lacquer alone. Patience, persistent care, and sometimes a mixed strategy make the biggest difference.
| Names | |
| Preferred IUPAC name | 6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1H)-one |
| Other names |
Ciclopirox olamine Ciclodan Loprox Penlac |
| Pronunciation | /ˌsaɪ.kloʊˈpɪr.ɑks/ |
| Identifiers | |
| CAS Number | 29342-05-0 |
| Beilstein Reference | 136264 |
| ChEBI | CHEBI:3694 |
| ChEMBL | CHEMBL1431 |
| ChemSpider | 5467 |
| DrugBank | DB01188 |
| ECHA InfoCard | 100.070.431 |
| EC Number | 201-647-4 |
| Gmelin Reference | 70334 |
| KEGG | D00241 |
| MeSH | D02.541.569.698.200.249 |
| PubChem CID | 2785 |
| RTECS number | GN6470000 |
| UNII | 19RRT353UP |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | 10000134 |
| Properties | |
| Chemical formula | C12H17NO2 |
| Molar mass | 207.273 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.1 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 2.59 |
| Vapor pressure | <0.0000001 mmHg (20°C) |
| Acidity (pKa) | 7.2 |
| Basicity (pKb) | 6.28 |
| Magnetic susceptibility (χ) | -79.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.528 |
| Viscosity | Viscous liquid |
| Dipole moment | 3.94 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 385.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -484.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -5205 kJ/mol |
| Pharmacology | |
| ATC code | D01AE14 |
| Hazards | |
| GHS labelling | GHS07, GHS08 |
| Pictograms | ⚠️🩸🔥🌡️ |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | Keep out of reach of children. For external use only. Avoid contact with eyes and mucous membranes. If irritation or sensitization develops, discontinue use and consult a physician. |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | > 204.6 °C |
| Autoignition temperature | 83°C |
| Lethal dose or concentration | LD50 (oral, rat): 2540 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, rat: 2,500 mg/kg |
| NIOSH | JN8278000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2% |
| Related compounds | |
| Related compounds |
Ciclopirox olamine Piroctone olamine Hydroxypyridones Clotrimazole Ketoconazole |
